A good quarter despite tepid sales growth for Dr Lal PathLabs
Dr Lal Pathlabs, a leading diagnostic company has come up with its Q2 Results. We look at the results and management commentary in this post. ...
Like our content? Join Capitalmind Premium.
- Equity, fixed income, macro and personal finance research
- Model equity and fixed-income portfolios
- Exclusive apps, tutorials, and member community
Subscribe Now
Or start with a free-trial
Already a subscriber?
Login Now
Related Posts
Waaree Energies: Powering India’s solar sector growth
The renewable energy world is changing fast, and Waaree Energies is leading the sector. But there's a big question on everyone's mind: Is renewable energy just ...
PG Electroplast: Diversifying and scaling to ride India’s EMS growth story
PGEL is one the leading ODM players in the country manufacturing products like air conditioners and washing machines. India's Consumer Electronics Market is ...
Unfolding the Sudarshan-Heubach deal
Sudarshan Chemicals announced its acquisition of Heubach Group, a 200-year-old pigment giant, sending its stock soaring 20%. While the market reacted ...